Zentek Ltd. (ZTEK)
| Market Cap | 118.66M |
| Revenue (ttm) | 29,132 |
| Net Income (ttm) | -7.95M |
| Shares Out | 104.06M |
| EPS (ttm) | -0.08 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,148 |
| Open | 1.170 |
| Previous Close | 1.140 |
| Day's Range | 1.090 - 1.170 |
| 52-Week Range | 0.500 - 1.480 |
| Beta | 0.76 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 11, 2025 |
About ZTEK
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in No... [Read more]
Financial Performance
In 2023, Zentek's revenue was 29,816, a decrease of -59.07% compared to the previous year's 72,855. Losses were -11.70 million, -18.80% less than in 2022.
Financial numbers in CAD Financial StatementsNews
Zentek Provides Update on ZenGUARD(TM) Enhanced Air Filters for the Canadian Market
GUELPH, ON / ACCESS Newswire / January 17, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to pro...
Zentek Subsidiary Albany Graphite Corp. Simplifies Process to Achieve Five Nines Purity
GUELPH, ON / ACCESSWIRE / January 8, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased t...
Zentek Provides Update on International Opportunities
GUELPH, ON / ACCESSWIRE / December 12, 2024 / Zentek Ltd. (" Zentek "or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has signed a Memor...
Zentek Ltd. Regains Nasdaq Compliance re Minimum Bid Price
GUELPH, ON / ACCESSWIRE / December 9, 2024 / Zentek Ltd. ("Zentek"or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that on Dece...
ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence
GUELPH, ON / ACCESSWIRE / November 27, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces its decisi...
Zentek and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology
GUELPH, ON / ACCESSWIRE / November 6, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd.
Zentek Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters
GUELPH, ON / ACCESSWIRE / October 31, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it has w...
Zentek Provides Market Update on ZenGUARD(TM) Antimicrobial Surgical Masks
GUELPH, ON / ACCESSWIRE / October 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide ...
Zentek Announces Voting Results of Annual and Special Meeting
Guelph, Ontario--(Newsfile Corp. - September 26, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company, announc...
Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Guelph, Ontario--(Newsfile Corp. - September 13, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") announces that on September 11, 2024, it received a written notification (th...
Zentek Announces Closing of Non-Brokered Private Placement of Units
Guelph, Ontario--(Newsfile Corp. - August 19, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased ...
Zentek Announces Upsize to Non-Brokered Private Placement of Units
Guelph, Ontario--(Newsfile Corp. - August 14, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased...
Zentek Announces Normal Course Issuer Bid
GUELPH, ON / ACCESSWIRE / August 14, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN) wishes to announce that, subject to regulatory approval, it will conduct a normal course iss...
Zentek Announces Preliminary Battery Results and University of Toronto Receives NSERC Mission Alliance Grant to Optimize Graphite for Battery Anode Use
GUELPH, ON / ACCESSWIRE / August 8, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to...
Zentek Launches National Sampling Program for ZenGUARD(TM) Antimicrobial Surgical Masks
GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will emb...
Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million
Guelph, Ontario--(Newsfile Corp. - July 23, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased to...
Zentek Subsidiary Albany Graphite Corp. Achieves Five Nines Purity for Albany Graphite
GUELPH, ON / ACCESSWIRE / July 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to a...
Zentek Announces Grant of Stock Options
GUELPH, ON / ACCESSWIRE / June 21, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN) announces the granting of options to acquire an aggregate of 1,935,000 common shares to certai...
Zentek Completes Case Study on HVAC Total Cost of Ownership Savings for the City of Toronto
GUELPH, ON / ACCESSWIRE / May 7, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company is pleased to announce t...
Zentek and Triera Biosciences Ltd. Achieve Positive Results Against Avian Influenza (H5N1) using Multivalent Aptamer Technology
GUELPH, ON / ACCESSWIRE / May 6, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd.
Zentek Announces Board and Management Changes
GUELPH, ON / ACCESSWIRE / May 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces the following cha...
Zentek Provides ZenGUARD(TM) Business Update
GUELPH, ON / ACCESSWIRE / April 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to...
Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions
GUELPH, ON / ACCESSWIRE / April 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce t...
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA
GUELPH, ON / ACCESSWIRE / March 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd.
Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA
GUELPH, ON / ACCESSWIRE / January 30, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) announces that its wholly-owned subsidiary Triera Biosciences Ltd.